Sage Journals: Discover world-class research

Open access

Research article

First published 2020

Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series

Helen Ma, Bin Cheng, Francesca Montanari [...]

Therapeutic Advances in Hematology

Free access

Review article

First published 2018-4

Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility

Polina Shindiapina, Lapo Alinari

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2019-10

Nivolumab induces impressive responses in relapsed/refractory classic Hodgkin lymphoma: Single institutional experience

Reyad Dada, Yazeed Zabani

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma

Sarah Tomassetti, Robert Chen, Savita Dandapani

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2022-3

Outpatient fractionated ICE protocol in relapsed/refractory lymphomas: Efficacy and safety

Reyad Dada, Ehab Mosaad Abdelghani, Tarek Boubakra [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2012-3

Targeting macrophages in classical Hodgkin’s lymphoma may seem rational,but is it safe?

Constantin A Dasanu

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2020

Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?

Ah-Reum Jeong, Edward D Ball, Aaron Michael Goodman

Clinical Medicine Insights: Oncology

Retricted access

Case report

First published 2022-7

Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma

Rosalaura V Villarreal-González, Sandra N González-Díaz, Wendy J Santos-Fernández [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2019-5

Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma

Vanessa Van-de-Velde, Youwen Zhou

Journal of Cutaneous Medicine and Surgery

Open access

Review article

First published 2020

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies

Theodoros P. Vassilakopoulos, John V. Asimakopoulos, Kostas Konstantopoulos [...]

Therapeutic Advances in Hematology

Search results